[Pj-16] Japanese Poster Session 16 Neuroimmunology 03

[Pj-16-1] An open-label extension study following the RIN-1 study: RIN-2 study

^○Masayuki Tahara¹, Tomoko Oeda¹, Kazumasa Okada², Kazuhide Ochi³, Hirofumi Maruyama⁴, Kyoichi Nomura⁵, Hikoaki Fukaura⁵, Ichiro Nakashima⁶, Tatsuro Misu⁷, Yuko Shimizu⁸, Atsushi Umemura⁹, Kenji Yamamoto⁹, Hideyuki Sawada⁹ (1.Clinical Research Center, NHO Utano National Hospital, Japan, 2.Department of Neurology, University of occupational and environmental Health, 3.Department of Neurology, Hiroshima City Medical Association-administered Hiroshima City Aki Hospital, 4.Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, 5.Department of Neurology, Saitama Medical University, 6.Department of Neurology, Tohoku medical and Pharmaceutical University, 7.Department of Neurology, Tohoku University Graduate School of Medicine, 8.Department of Neurology,Tokyo Women's Medical University School of Medicine, 9.Department of Neurology, NHO Utano National Hospital)

1998年　滋賀医科大学　第三内科入局
1999年　第二岡本総合病院　神経内科
2003年　滋賀医科大学大学院　入学（2006年医学博士）
2006年　国立病院機構　宇多野病院　神経内科
2011年　国立病院機構　宇多野病院　リハビリテーション科医長
2017年　国立病院機構　宇多野病院　臨床研究部　免疫研究室長　併任
　　　　　～現在に至る